MedPath

Effect of Vitamin D3 and Omega-3FA on Leptin and HbA1C With Vitamin D Deficiency

Not Applicable
Completed
Conditions
Vitamin D Deficiency
Interventions
Dietary Supplement: omega 3 FA group
Dietary Supplement: VD3 and omega- 3FA group
Other: control group
Dietary Supplement: VD3 group
Registration Number
NCT03735303
Lead Sponsor
Applied Science Private University
Brief Summary

The Combined effect of Vitamin D3 and Omega-3 supplements on serum leptin and Glycated hemoglobin (Hb A1C) levels in Jordanian people with vitamin D deficiency.

Detailed Description

Nothing is published in the literature about effect of vitamin D3 (VD3) and omega-3 fatty acids (omega-3FA) on serum leptin and glycated hemoglobin ( HbA1C)

This study will be conducted to investigate effect of VD3 and omega-3FA alone and with each other on serum leptin and Glycated hemoglobin (Hb A1C) levels in Jordanian people with vitamin D deficiency.

This randomized, controlled clinical trial will be designed to test effects of 50,000 IU VD3 weekly and 1000 mg omega-3FA daily for eight weeks, separately and with each other, on on serum leptin and Glycated hemoglobin (Hb A1C) levels .

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
146
Inclusion Criteria
  • jordanian people aged 25-55
  • medical diagnosis of vitamin D deficiency ( VD <25 ng/ ml)
Exclusion Criteria
  • Blood disorders including
  • thalassemia
  • sickle cell disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
omega 3- FA groupomega 3 FA groupdietary supplement : omega 3- FA group 1000 mg wild salmon and fish oil complex (contain 300 mg of omega 3-FA) once daily for 8 weeks
VD3 and omega 3 FA groupVD3 and omega- 3FA groupdietary supplement : VD3 and omega-3FA 50000 IU VD3/week for 8 weeks and 1000 mg wild salmon and fish oil complex (contain 300 mg of omega 3-FA) once daily for 8 weeks
control groupcontrol groupno intervention was given
VD3 groupVD3 groupdietary supplement : VD3 group treated with 50000 IU VD3/ week for 8 weeks
Primary Outcome Measures
NameTimeMethod
HbA1C8 weeks

plasma concentration of HbA1C

leptin8 weeks

serum level of leptin

VD 38 weeks

Serum level of 25-hydroxyvitamin D

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Applied Science University

🇯🇴

Amman, Jordan

© Copyright 2025. All Rights Reserved by MedPath